Is Someone Sneaking A Peek At Business Week?

Early trading of a few Inside Wall Street stocks raises a red flag

On most Thursday mornings, Seymour Zucker, the senior editor who oversees BUSINESS WEEK's Inside Wall Street column, sits down at a Bloomberg terminal and watches the market. On Thursday, Jan. 18, his attention was caught by Creative Biomolecules, a tiny biotech company that was favorably discussed in that week's column. All morning, the stock had hovered around 9. Then, at about 1 p.m., it began climbing--to 10--on heavy volume. "It really hit me between the eyes," recalls Zucker. In all, some 692,000 shares were traded, vs. an average volume of 245,500 during the previous five days.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.